Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Palisade Bio (PALI)
NASDAQ:PALI
Holding PALI?
Track your performance easily
PALI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.18 - $22.35
Previous Close$2.84
Volume79.50K
Average Volume (3M)72.96K
Market Cap
$3.70M
Enterprise Value-$7.50M
Total Cash (Recent Filing)$11.35M
Total Debt (Recent Filing)$154.00K
Price to Earnings (P/E)―
Beta2.71
Next Earnings
Nov 11, 2024EPS Estimate
-$3.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-20.10
Shares Outstanding1,184,487
10 Day Avg. Volume309,745
30 Day Avg. Volume72,962
Standard Deviation0.27
R-Squared0.07
Alpha-0.10
Financial Highlights & Ratios
Price to Book (P/B)0.30
Price to Sales (P/S)13.46
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-30.01
Enterprise Value/Ebitda0.53
Forecast
1Y Price Target
$22.50Price Target Upside782.35% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Palisade Bio News
PremiumCompany Announcements
Palisade Bio CEO Finley’s Revised Employment and Compensation Deal
Ownership Overview
5.17% Insiders
1.12% Mutual Funds
2.10% Other Institutional Investors
91.28% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
PALI FAQ
What was Palisade Bio’s price range in the past 12 months?
Palisade Bio lowest stock price was $2.18 and its highest was $22.35 in the past 12 months.
What is Palisade Bio’s market cap?
Currently, no data Available
When is Palisade Bio’s upcoming earnings report date?
Palisade Bio’s upcoming earnings report date is Nov 11, 2024 which is tomorrow.
How were Palisade Bio’s earnings last quarter?
Palisade Bio released its earnings results on Aug 13, 2024. The company reported -$3.32 earnings per share for the quarter, missing the consensus estimate of -$2.93 by -$0.39.
Is Palisade Bio overvalued?
According to Wall Street analysts Palisade Bio’s price is currently Undervalued.
Does Palisade Bio pay dividends?
Palisade Bio does not currently pay dividends.
What is Palisade Bio’s EPS estimate?
Palisade Bio’s EPS estimate is -$3.35.
How many shares outstanding does Palisade Bio have?
Palisade Bio has 1,329,516 shares outstanding.
What happened to Palisade Bio’s price movement after its last earnings report?
Palisade Bio reported an EPS of -$3.32 in its last earnings report, missing expectations of -$2.93. Following the earnings report the stock price went up 1.093%.
Which hedge fund is a major shareholder of Palisade Bio?
Currently, no hedge funds are holding shares in PALI
---
Palisade Bio Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$22.50 (782.35% Upside)
$22.50 (782.35% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.7%
Last 30 Days ▼ 0.5%
Last 30 Days ▼ 0.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-67.07%
12-Months-Change
Fundamentals
Return on Equity
-110.22%
Trailing 12-Months
Asset Growth
-29.63%
Trailing 12-Months
Company Description
Palisade Bio
Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.
---
PALI Stock 12 Month Forecast
Average Price Target
$22.50
▲(782.35% Upside)
Technical Analysis
Bioxcel Therapeutics
―
Leap Therapeutics
―
TRACON Pharmaceuticals
―
Adial Pharmaceuticals
―
Best Analysts Covering PALI
1 Year
1 Year Success Rate
0/13 ratings generated profit
1 Year Average Return
-59.28%
reiterated a buy rating last month
Copying Naz Rahman's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -59.28% per trade.
---